Novocure provides cancer patients with a novel treatment for aggressive cancers using Tumor Treating Fields (TTFields). The Senior Manager, Product Management will lead cross-functional strategy and readiness for consumable equipment and accessories (both sterile and non-sterile) that are integral to Novocure’s medical device systems. The ideal candidate will have direct experience with Class II and/or Class III medical devices and their consumables, operating within highly regulated development environments under FDA and EU MDR frameworks. This includes responsibility from concept through end-of-life for consumables supporting device performance, patient usability, and regulatory compliance.
This is a full-time, exempt position located in our Portsmouth, NH office.
ESSENTIAL DUTIES AND RESPONSIBILITIES:
QUALIFICATIONS/KNOWLEDGE:
OTHER:
Novocure is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sexual orientation, gender identity, age, national origin, disability, protected veteran status or other characteristics protected by federal, state, or local law. We actively seek qualified candidates who are protected veteran and individuals with disabilities as defined under VEVRAA and Section 503 of the Rehabilitation Act.
Novocure is committed to providing an interview process that is inclusive of our applicant’s needs. If you are an individual with a disability and would like to request an accommodation, please email NovocureRecruitingEEO@novocure.com
ABOUT NOVOCURE:
Our vision
Patient-forward: aspiring to make a difference in cancer.
Our patient-forward mission
Together with our patients, we strive to extend survival in some of the most aggressive forms of cancer by developing and commercializing our innovative therapy.
Our patient-forward values
– innovation
– focus
– drive
– courage
– trust
– empathy
#LI-RJ1

We are a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of our innovative therapy, Tumor Treating Fields. Our commercialized products are approved in certain countries for the treatment of adult patients with glioblastoma and in the U.S. for the treatment of adult patients with malignant pleural mesothelioma. We have ongoing or completed clinical trials investigating Tumor Treating Fields in brain metastases, non-small cell lung cancer, pancreatic cancer, ovarian cancer, liver cancer and gastric cancer.
Headquartered in Switzerland, Novocure has U.S. operations in Portsmouth, New Hampshire and Chesterbrook, Pennsylvania. Additionally, Novocure has offices in Canada, Germany, Japan, Poland and Israel.